Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Duke University
- Study ID
- NCT07738874
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Retinopathy of Prematurity (ROP)
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Days - 9 Months
- Healthy Volunteers
- Not accepted
Interventions
- Ultra-widefield Optical Coherence Tomography (UWF-OCT) — DEVICEHandheld retinal OCT imaging at the bedside or in clinic with an ultra-widefield handheld optical coherence tomography
- Wide-field ophthalmic imaging system — DEVICEHandheld wide-field ophthalmic fundus imaging at the bedside or in clinic
Study Details
Retinopathy of prematurity (ROP) is a disorder of development of the retina and its vasculature that can impact vision in vulnerable preterm neonates for a lifetime. A major barrier to improving ROP outcomes is the lack of easy access and low stress means to obtain objective measures of ROP disease severity across the retina in these infants. The long-term goal of this program is to provide information which will improve preterm infant health and vision via objective bedside imaging and analysis that characterizes retina-wide ROP level of disease, its response to treatment and development, and to rapidly translate this for better early intervention and improved future vision care.
Key Dates
- First listed
- Jul 31, 2026
- Start date
- Jul 1, 2026
- Status verified
- Jul 2026
- Primary completion
- Jun 30, 2031
- Completion
- Dec 31, 2031
Study Design
- Enrollment
- 175 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Test bedside UWF-OCT versus bionocular indirect ophthalmoscopic exam to identify RW-ROP and TR-ROP175 infants at risk for retinopathy of prematurity will be enrolled and have beside ultra-widefield OCT retinal imaging and standard-of-care binocular indirect ophthalmoscopic (BIO) exam.
- Experimental: Test bedside UWF-OCT versus fundus photos to identify RW-ROP and TR-ROP455 infants at risk for retinopathy of prematurity: 175 infants will be enrolled and have beside ultra-widefield OCT retinal imaging, fundus imaging, and binocular indirect ophthalmoscopic exam. Data from newly enrolled infants will be combined with 280 infants who had similar imaging in BabySTEPS1, BabySTEPS2, and the Duke Investigational Pediatric OCT study to perform artificial intelligence (AI) based RW-ROP and TR-ROP severity assessment and to add OCT risk measures to AI-based prediction of RW-ROP and TR-ROP.
- Experimental: Test UWF-OCT versus binocular indirect ophthalmoscopic exam to characterize ROP regression45 infants treated for ROP: Compare OCT measures to clinical findings of ROP regression and identify early signs of ROP reactivation.
Primary Outcome Measure
Sensitivity and specificity of ultra-widefield OCT vs bionocular indirect ophthalmoscopy or fundus photograph to identify referral-warranted retinopathy of prematurity [ Time Frame: Up to 60 weeks post-menstrual age ]
Central Contacts
- Xi Chen, MD919-684-8434
- Michelle N McCall, MCAPM, BA919-684-0544
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University Eye Center | Durham | North Carolina | 27705 | Xi Chen, MD, PhD (PRINCIPAL_INVESTIGATOR) Cynthia A Toth, MD (SUB_INVESTIGATOR) Sharon F Freedman, MD (SUB_INVESTIGATOR) Sasapin G Prakalapakorn, MD (SUB_INVESTIGATOR) Roarke Horstmeyer, PhD (SUB_INVESTIGATOR) |
| University of Pennsylvania, Center for Preventive Ophthalmology and Biostatistics | Philadelphia | Pennsylvania | 19104 | - |
Find similar trials in Durham, NC
Related Studies
- Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of PrematurityRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Safety, PK and PD of FLQ-101 in Premature NeonatesPHASE1 · Recruiting · FELIQS INC. · Austin, Texas